Zontivity Side Effects
Generic name: vorapaxar
Medically reviewed by Drugs.com. Last updated on Nov 6, 2024.
Note: This document provides detailed information about Zontivity Side Effects associated with vorapaxar. Some dosage forms listed on this page may not apply specifically to the brand name Zontivity.
Applies to vorapaxar: oral tablet.
Important warnings
This medicine can cause some serious health issues
Oral route (tablet)
Antiplatelet agents increase the risk of bleeding, including intracranial hemorrhage (ICH) and fatal bleeding.
Do not use vorapaxar in patients with active pathological bleeding or a history of stroke, TIA, or ICH.
Serious side effects of Zontivity
Along with its needed effects, vorapaxar (the active ingredient contained in Zontivity) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking vorapaxar:
Less common side effects
- bloody or black, tarry stools
- constipation
- pale skin
- severe stomach pain
- troubled breathing with exertion
- unusual bleeding or bruising
- unusual tiredness or weakness
- vomiting of blood or material that looks like coffee grounds
Other side effects of Zontivity
Some side effects of vorapaxar may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common side effects
- discouragement
- feeling sad or empty
- irritability
- lack of appetite
- loss of interest or pleasure
- rashes
- trouble concentrating
- trouble sleeping
For healthcare professionals
Applies to vorapaxar: oral tablet.
General adverse events
Bleeding, including life-threatening and fatal bleeding, is the most commonly reported adverse reaction.[Ref]
Hematologic
Dermatologic
- Common (1% to 10%): Rashes, eruptions, exanthemas[Ref]
Gastrointestinal
- Common (1% to 10%): Gastrointestinal bleeding[Ref]
Ocular
- Common (1% to 10%): Retinopathy or retinal disorder, diplopia/oculomotor disturbances[Ref]
Nervous system
- Uncommon (0.1% to 1%): Intracranial bleeding[Ref]
References
1. (2014) "Product Information. Zontivity (vorapaxar)." Merck & Co., Inc
More about Zontivity (vorapaxar)
- Check interactions
- Compare alternatives
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: protease-activated receptor-1 antagonists
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Zontivity side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.